Literature DB >> 3317737

Q fever: current concepts.

L A Sawyer1, D B Fishbein, J E McDade.   

Abstract

Persons with Q fever usually present with severe retrobulbar headache, a fever to 104 degrees F or higher with shaking chills, general malaise, myalgia, chest pain, and sometimes pneumonia and hepatitis. Cattle, sheep, goats, and ticks are the primary reservoirs of the etiologic agent, Coxiella burnetii. Humans are usually infected by inhaling infectious aerosols. Because C. burnetii can survive for long periods in the environment, it poses a continuing health hazard once it is disseminated. Q fever usually occurs sporadically, but large outbreaks are frequently observed throughout the world, particularly among abattoir workers and personnel working in research centers. Q fever endocarditis follows a chronic course and is frequently fatal. Tests for antibodies to C. burnetii are required for confirmation of the diagnosis. Tetracyclines remain the mainstay of treatment for acute Q fever, and tetracyclines in combination with other antibiotics have been advocated for patients with Q fever endocarditis. Vaccines for Q fever have been proven effective in clinical trials.

Entities:  

Mesh:

Year:  1987        PMID: 3317737     DOI: 10.1093/clinids/9.5.935

Source DB:  PubMed          Journal:  Rev Infect Dis        ISSN: 0162-0886


  50 in total

1.  Primary humoral antibody response to Coxiella burnetii, the causative agent of Q fever.

Authors:  D Guigno; B Coupland; E G Smith; I D Farrell; U Desselberger; E O Caul
Journal:  J Clin Microbiol       Date:  1992-08       Impact factor: 5.948

2.  Q fever in Quebec (1989-93): Report of 14 cases.

Authors:  M Goyette; A Poirier; J Bouchard; E Morrier
Journal:  Can J Infect Dis       Date:  1994-05

Review 3.  Immunomodulation with microbial vaccines to prevent type 1 diabetes mellitus.

Authors:  Nikolai Petrovsky
Journal:  Nat Rev Endocrinol       Date:  2010-03       Impact factor: 43.330

Review 4.  Immunologic tests in the diagnosis of pulmonary infection.

Authors:  E Goldstein; J Koo
Journal:  Clin Rev Allergy       Date:  1990 Summer-Fall

5.  Profiling the humoral immune response of acute and chronic Q fever by protein microarray.

Authors:  Adam Vigil; Chen Chen; Aarti Jain; Rie Nakajima-Sasaki; Algimantas Jasinskas; Jozelyn Pablo; Laura R Hendrix; James E Samuel; Philip L Felgner
Journal:  Mol Cell Proteomics       Date:  2011-08-04       Impact factor: 5.911

6.  Most common clinical presentation of Q fever in a province in the north of Spain.

Authors:  F J Merino; T Nebreda; A Campos
Journal:  Eur J Epidemiol       Date:  1998-10       Impact factor: 8.082

7.  Serological examination of human and animal sera from six countries of three continents for the presence of rickettsial antibodies.

Authors:  E Kovácová; W Sixl; D Stünzner; J Urvölgyi; J Kazár
Journal:  Eur J Epidemiol       Date:  1996-02       Impact factor: 8.082

Review 8.  Invasion of the central nervous system by intracellular bacteria.

Authors:  Douglas A Drevets; Pieter J M Leenen; Ronald A Greenfield
Journal:  Clin Microbiol Rev       Date:  2004-04       Impact factor: 26.132

9.  Evaluation of Coxiella burnetii antibiotic susceptibilities by real-time PCR assay.

Authors:  Robert E Brennan; James E Samuel
Journal:  J Clin Microbiol       Date:  2003-05       Impact factor: 5.948

10.  An epidemiological study of an outbreak of Q fever in a secondary school.

Authors:  L R Jorm; N F Lightfoot; K L Morgan
Journal:  Epidemiol Infect       Date:  1990-06       Impact factor: 2.451

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.